Oct 26 (Reuters) - Mayne Pharma Group Ltd MYX.AX :
* ACQUIRED HALOBETASOL FOAM 0.05% FOR AN INVESTMENT OF UP TO US$32.0 MILLION AND AN ONGOING EARN OUT PAYMENT
* MAYNE PHARMA WILL FUND ACQUISITION FROM CASH AND UNDRAWN DEBT
* MAYNE PHARMA WILL FUND ACQUISITION FROM CASH AND UNDRAWN DEBT
* EXPECTED TO BE ACCRETIVE TO EARNINGS IN FIRST FULL YEAR FOLLOWING COMMERCIALISATION (FY20)
* ANTICIPATES SPENDING APPROXIMATELY US$4 MILLION IN FY19 TO LAUNCH HALOBETASOL FOAM
* EXPECTS PEAK SALES POTENTIAL TO EXCEED US$25 MILLION